ArticleBMC infectious diseases2026
Cigarette smoking and SARS-CoV-2 infection: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEvidence of whether smoking affects the risk for SARS-CoV-2 infection is mixed. We aimed to clarify the inconsistencies in previous findings and whether the association is potentially causal using different Mendelian randomization (MR) methods.
methodsWe examined associations between smoking traits (initiation, cessation, and intensity) and SARS-CoV-2 infection in multivariable logistic regression, and one-sample and two-sample MR analyses. The study included n = 47,506 female and n = 28,229 male study subjects from the Norwegian Mother, Father, and Child Cohort Study (MoBa) with questionnaire data and genotype information. SARS-CoV-2 infection status was obtained by data linkage to the national health registry MSIS.
resultsWe found no clear evidence of an association between smoking initiation and SARS-CoV-2 infection (multivariable regression: OR 1.08, 95% CI 0.96 to 1.20, one-sample multivariable MR analysis: OR 1.02, 95% CI 0.96 to 1.09, two-sample MR: OR 1.10 (95% CI 1.06 to 1.13). Also, we found no clear evidence of an association with smoking intensity (multivariable regression: OR 0.78, 95% CI 0.62 to 0.96, one-sample multivariable MR: OR 1.04, 95% CI 0.76 to 1.42, two-sample MR: OR 1.01, 95% CI 0.95 to 1.09, per 1 SD increase in number of cigarettes per day). Nor was there any association with smoking cessation. These findings did not change after accounting for educational level, BMI or risk-taking behavior in multivariable MR analyses.
conclusionsWe did not find robust evidence of causal associations between smoking and SARS-CoV-2 infection. Our investigation of potential violations to MR assumptions highlights the limitations of this approach to examine infection risk associated with smoking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.